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Propionic acidemia is one of the rare congenital neurometabolic disorders with 
autosomal recessive inheritance. This disorder is caused by a defect in the 
propionyl-CoA carboxylase enzyme and can be presented with life-threatening 
ketoacidosis, lethargy, failure to thrive, and developmental delay. 
Materials & Methods
The patients diagnosed as having propionic acidemia in Neurology Department 
of Mofid Children’s Hospital in Tehran, Iran, between 2002 and 2012 were 
include in our study. This disorder was confirmed by clinical manifestations, 
neuroimaging findings, and neurometabolic assessment in the reference 
laboratory in Germany. Our study was conducted to define the sex, age, gender, 
past medical history, developmental status, clinical findings, and neuroimaging 
manifestations in 10 patients with propionic acidemia.
Results
Seventy percent of patients were offspring of consanguineous marriages. In this 
study, only one patient had microcephaly at birth, but at detection time, 30% of 
patients had head circumference and weight below the 3rd percentile.
The patients were followed for approximately 5 years and this follow-up showed 
that the patients with early diagnosis had a more favorable clinical response. 
Neuroimaging findings included brain atrophy, white matter and globus pallidus 
involvement.
Conclusion
Finally we suggest that early diagnosis and treatment have an important role in 
the prevention of disease progression 
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Introduction
Propionic acidemia is a disorder of organic acid metabolism with recessively 
inheritance, characterized by a spectrum of clinical and biochemical 
manifestations. The main feature of this disorder is metabolic acidosis, which is 
useful in differentiating it from non-ketotic hyperglycinemia (1).
Diagnosis of propionic acidemia is made by mass spectrometry, gas 
chromatography, and urine excretion of methylcitrate and 3-hydroxy-propionate 
(2).
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autistic manner and another had fear and hallucination. 
Thirty percent of patients had a history of neonatal 
hospitalization because of recurrent vomiting and 
narcosis. Thirty percent of patients had a history 
of neonatal hospitalization because of respiratory 
disorders. Growth index at birth in all patients was 
normal, except in one patient with microcephaly, but at 
detection time, 30% of patients had head circumference 
and weight below the 3rd percentile.
Developmental delay and developmental regression 
were seen in 90% and 60% of the patients, respectively. 
Twenty percent of patients had a specific face 
(micrognathia and saddle nose). Thirty percent 
of patients had movement disorder as dystonia. 
Hypertonicity was seen in 30% of them, and 40% of 
patients with propionic aciduria had hypotonicity.
Fifty percent of patients had seizure (40% had tonic 
seizure and one patient had GTC). None of the patients 
had refractory seizure. Thirty percent of patients had 
agitation and irritability. Fundoscopic examination was 
normal, and there was no certain point in other physical 
examination (hair and skin, face, chest, and abdomen). 
In lab data, 40% of patients had decreased levels of 
hemoglobin, 30% had elevated levels of AST and 
ALT, 60% had increased levels of ammoniac and 
lactate, 20% had decreased level of blood sugar, and 
40% had metabolic acidosis. Other biochemistry tests 
were normal in all of the patients. In the sonography 
of one patient, multiple renal stones were reported. 
Electroencephalography (EEG) in 4 patients was 
abnormal and had no special pattern. In neuroimaging 
data, 70% of patient had abnormal findings in brain 
MRI [4 patients (40%) had brain atrophy, 4 patients 
(40%) white matter involvement, and 3 patients (30%) 
globus pallidus involvement] (Figure 1).
Discussion 
Propionic acidemia is a rare metabolism disorder 
with recessive inheritance, caused by a defect in the 
activity of the mitochondrial enzyme propionyl-CoA 
carboxylase enzyme (7). Several hours after birth, 
the clinical manifestations are started with initiation 
of protein intake in diet. The main symptoms of 
this disorder are recurrent metabolic acidosis with 
hyperlactatemia and ketosis, which are precipitated by 
The main features of this disorder are based on 
recurrent vomiting, ketosis, hypotonia, difficult 
feeding, lethargy, hyperglycinemia, episodes of seizure 
and hyperammonemia during the acute episodes of this 
disorder (3,4).
There are a broad spectrum of neurological symptoms 
and signs, including structural abnormalities, 
neurodevelopmental delay, metabolic stroke-like 
episodes, cranial nerve abnormalities, and seizures (5). 
When the metabolic demand is increased, patients’ 
deterioration occurs (6).
In this study, we present 5 years of experience about 
propionic acidemia in Pediatric Neurology Research 
Center of Mofid Children’s Hospital in Tehran, Iran 
and we describe 10 cases of this disorder with clinical 
symptoms and neuroimaging findings.
Materials & Methods 
Patients were diagnosed as propionic acidemia based 
on clinical manifestations, neuroimaging findings, 
and finally laboratory assessment of propionic acid at 
metabolic disorders laboratory in Germany. Assessment 
information was collected as age, gender, past medical 
history, development status, general appearance, and 
clinical and neuroimaging findings. The data were 
analyzed using descriptive method and no statistical 
testing was applied as observational study.
Prevention included genetic counseling and reducing 
new cases of disorder.
Results
Ten patients were included in this study. They 
were evaluated in terms of clinical, laboratory, and 
neuroimaging findings. Seven patients were male and 
three were female, and the age range was 1-48 months. 
The earliest case was diagnosed at birth and the late case 
was diagnosed at age of 4. The mean age of patients at 
detection time was 31.2 months. Seventy percent of the 
patients were offspring of consanguineous marriages. 
In 60% of patients, the family history of neurological 
disorder was positive (mental retardation and seizure). 
The first and chief complaint in 70% of the patients was 
neurological disorders, such as developmental delay 
and seizure. Two patients had cognitive regression 
and were unresponsive to sound. One patient had 
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infection and protein intake (8).
The management of propionic acidemia is based on a 
low protein diet and L-carnitine to elevate propionic 
acid renal clearance. For acute phase of this disorder 
with hyperammonemia and acidosis, hydration and 
fluid therapy along with treatment of concomitant 
complications can be useful (6,9). Because of recurrent 
episode of metabolic acidosis despite of conservative 
management, the outcome of propionic acidosis is 
disappointing (10). 
Seventy percent of our patients were offspring of 
consanguineous marriages. In this study, 30% of 
patients had a history of neonatal hospitalization 
because of recurrent vomiting and narcosis, and 30% 
had a history of neonatal hospitalization because of 
respiratory disorders.
In a study by Ozand PT and collaborators on 25 patients 
with propionic acidemia (14 patients presented with 
acidosis, hyperammonemia, and thrombocytopenia in 
acute phase and 11 patients presented with unusual 
and unspecific symptoms), all the patients had a 
severe vomiting that they were diagnosed as intestinal 
obstruction in referral hospitals; Three patients 
had an immune disorder as the first manifestation 
of hospitalization; and 4 patients had an acute or 
chronic encephalopathy as the first manifestation of 
propionic acidemia. The clinical picture of propionic 
acidemia includes nipple and facial dysmorphia, 
vomiting, and hypotonia. Severe thrombocytopenia 
was occurred as a hallmark of the metabolic crisis. 
In one patient, intracranial hemorrhage was seen, and 
in 3 patients, intracranial hemorrhage caused death 
(11). Neuropathologic findings in this disorder have 
not been characterized, but white matter spongiosis in 
neonates is seen, most prominently at the junction of 
gray-white matter of the temporal cortex, and also at 
the tracts of midbrain, pons, and medulla (12). There is 
a report of hemorrhage in the basal ganglia in a patient 
with propionic acidemia, probably due to increase in 
sensitivity of endothelial cells to toxic insults (13). 
Neuroimaging findings of neonates reveals white 
matter attenuation on computed tomography (CT) 
scanning and magnetic resonance imaging (MRI), 
which resolve after 1 year, with only a slight symmetric 
change in the basal ganglia (14). A study by Bergman 
et al. showed that the brain MRI of the patients with 
propionic acidemia revealed delayed myelination and 
cerebral atrophy (15). 
In this study, in neuroimaging data, 70% of patient had 
abnormal findings in brain MRI, 4 (40%) had brain 
atrophy, 4 (40%) had white matter involvement, and 3 
(30%) had globus pallidus involvement.
In our study and 5-year follow-up, motor and cognition 
delay improved significantly. Fifty percent of patient 
with microcephaly after 6-9 month follow-up and 
treatment had acceptable head circumference pickup 
and growth weight. Fear, hallucination, and sleep 
disorder in one patient resolved by management 
therapy. Ketoacidotic attacks and loss of consciousness 
resolved after starting treatment. In one patient who 
was diagnosed at birth and treatment was started 
immediately, neuroimaging was normal after one year. 
Seventy percent of refractory seizure was controlled 
with antiepileptic drug and L-carnitin. Similar to Ozand 
study, brain atrophy and demyelination of white matter 
were improved partially, but basal ganglia involvement 
did not resolve completely.
In conclusion, in our study, 70% of patients were 
offspring of consanguineous marriages and 60% of 
patients had a positive family history of neurologic 
Fig1. Brain MRI changes in a 4-year-old boy with 
propionic acidemia
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disorders. So, consanguinity and positive family 
history are the most important factors in diagnosis of 
suspected patients. 
Acknowledgments
We thank Wagnester laboratory in Germany for 
conducting laboratory tests of neurometabolic 
disorders. Also, we thank the parents of the patients for 
their cooperation and permission to publish this study.
Authors’ contributions
PK was responsible for study design and collection and 
interpretation of clinical data and oversaw all stages 
of revision and editing. NJ contributed in collection 
of data and wrote the first draft of this manuscript. 
Other coauthors were involved in data collection and 
interpretation. All authors reviewed the draft of this 
article and agreed to submit the final version of the 
manuscript.
Declaration of conflicting interests
None declared.
Funding
The authors received no financial support for the 
research and publication of this article.
Ethical approval 
Institutional ethical approval for the conduct of this 
study was obtained from the Pediatric Neurology 
Research Center of Shahid Beheshti University of 
Medical Sciences, Tehran, Iran. All parents signed a 
written consent for participation in the study.
References
1. Ramachandran R, Pietz J. Propionic acidemia without 
acidemia: a case report. J Perinatol 1995;15(1):71-3.
2. Figueras Aloy J, Ribes Rubio A, Vilaseca Busca MA, 
Lluch Mir M, Brines Godino P, Jiménez González R, et 
al. [The neonatal form of propionic acidemia]. An Esp 
Pediatr 1988;29(6):459-62.
3. Yuan L. [Propionic acidemia: one case report]. Zhongguo 
Yi Xue Ke Xue Yuan Xue Bao 1991;13(2):141-3.
4. Hsu WC, Lin SP, Huang FY, Wang PA, Hsiao 
KJ. [Propionic acidemia: report of a case that is 
successfully managed by peritoneal dialysis and sodium 
benzoate therapy]. Zhonghua Yi Xue Za Zhi (Taipei) 
1990;46(5):306-10.
5. Schreiber J, Chapman KA, Summar ML, Ah Mew N, 
Sutton VR, MacLeod E, et al. Neurologic considerations 
in propionic acidemia. Mol Genet Metab 2012;105(1):10-
5.
6. Chapman KA, Gropman A, MacLeod E, Stagni K, 
Summar ML, Ueda K, et al. Acute management of 
propionic acidemia. Mol Genet Metab 2012;105(1):16-25. 
7. Ryu J, Shin YH, Ko JS, Gwak MS, Kim GS.Intractable 
metabolic acidosis in a child with propionic acidemia 
undergoing liver transplantation -a case report. Korean J 
Anesthesiol 2013;65(3):257-61.  
8. Fernandes J, Saudubray JM, Berghe GVD, Walter 
JH. Inborn Metabolic Diseases. 4th ed. Berlin: 
Springer;2006. P.247–256.
9. Sutton VR, Chapman KA, Gropman AL, MacLeod 
E, Stagni K, Summar ML, et al. Chronic management 
and health supervision of individuals with propionic 
acidemia. Mol Genet Metab 2012;105(1):26-33.
10. Lehnert W, Sperl W, Suormala T, Baumgartner 
ER. Propionic acidaemia: clinical, biochemical and 
therapeutic aspects. Experience in 30 patients. Eur J 
Pediatr 1994;153(7 Suppl. 1):S68–S80.
11. Ozand PT, Rashed M, Gascon GG, Youssef NG, Harfi 
H, Rahbeeni Z, et al. Unusual presentations of propionic 
acidemia. Brain Dev 1994;16(Suppl):46-57.
12. Feliz B, Witt DR, Harris BT. Propionic acidemia: a 
neuropathology case report and review of prior cases. 
Arch Pathol Lab Med 2003;127(8):e325-8.
13. Hamilton RL, Haas RH, Nyhan WL, Powell HC, Grafe 
MR. Neuropathology of propionic acidemia: a report of 
two patients with basal ganglia lesions. J Child Neurol 
1995;10:25-30.
14. Brismar J, Ozand PT. CT and MR of the brain in disorders 
of the propionate and methylmalonate metabolism. Am 
J Neuroradiol 1994;15(8):1459-73.
15. Bergman AJ, Van der Knaap MS, Smeitink JA, Duran 
M, Dorland L, Valk J, et al. Magnetic resonance imaging 
and spectroscopy of the brain in propionic acidemia: 
clinical and biochemical considerations. Pediatr Res 
1996;40(3):404-9.
